Literature DB >> 3285468

Essential fatty acid depletion of renal allografts and prevention of rejection.

G F Schreiner1, W Flye, E Brunt, K Korber, J B Lefkowith.   

Abstract

A central hypothesis in transplantation biology is that resident leukocytes expressing class II histocompatibility antigens may determine the immunogenicity of an organ. By means of a novel method to deplete the kidney of resident leukocytes, essential fatty acid deficiency (EFAD), this hypothesis was tested in an intact, vascular organ. Kidneys subjected to EFAD and thus depleted of resident Ia-positive macrophages survived and functioned when transplanted across a major histocompatibility antigen barrier in the absence of immunosuppression of the recipient. Control allografts were rejected promptly. Allografts from donors subjected to EFAD normalized their lipid composition and were repopulated with host macrophages by 5 days. Administration of Ia-positive cells at the time of transplantation established that the resident leukocyte depletion induced by EFAD was responsible for the protective effect. These observations may provide insights into the mechanisms underlying tissue immunogenicity and the population of normal tissues with resident leukocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3285468     DOI: 10.1126/science.3285468

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  7 in total

Review 1.  Post-transplant hyperlipidaemia.

Authors:  R M Jindal
Journal:  Postgrad Med J       Date:  1997-12       Impact factor: 2.401

Review 2.  Enteral nutrition as primary therapy in Crohn's disease.

Authors:  F Fernández-Bañares; E Cabré; F González-Huix; M A Gassull
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

3.  High osmolality-low pH flush solutions improve renal transplant function in rats.

Authors:  R Kline; M Churchill; P Churchill; A Bidani; M Schwartz
Journal:  Urol Res       Date:  1991

4.  IL-1 produced and released endogenously within human islets inhibits beta cell function.

Authors:  M Arnush; M R Heitmeier; A L Scarim; M H Marino; P T Manning; J A Corbett
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

5.  Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial.

Authors:  F González-Huix; R de León; F Fernández-Bañares; M Esteve; E Cabré; D Acero; A Abad-Lacruz; M Figa; M Guilera; R Planas
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

6.  Development and characterization of essential fatty acid deficiency in human endothelial cells in culture.

Authors:  R Lerner; P Lindström; A Berg; E Johansson; K Rosendahl; J Palmblad
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

7.  Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1.

Authors:  Sarah A Steer; Anna L Scarim; Kari T Chambers; John A Corbett
Journal:  PLoS Med       Date:  2005-12-20       Impact factor: 11.069

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.